Clinical Trials | November 24, 2025
Bayer’s experimental stroke drug could reshape secondary stroke prevention
Millions of stroke survivors across the world may soon have a new defense
Millions of stroke survivors across the world may soon have a new defense
Fenebrutinib targets cells in the immune system known as B cells and microglia
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
Increases speed to market for drug developers working on nucleic acid therapeutics
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Around 7% of the Indian population suffers from IBS
The approval marks a significant milestone for the American pharmaceutical company in the field of UC
More than 10,000 scientific publications containing EUDRAGIT
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Subscribe To Our Newsletter & Stay Updated
